Jonathan Steuve

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without <i>MGMT</i> Promoter Hypermethylation (EORTC 26082)

Wolfgang Wick, Thierry Gorlia, Pierre Bady et al. · Clinical Cancer Research · 2016 · 155 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

DiC14‐amidine cationic liposomes stimulate myeloid dendritic cells through Toll‐like receptor 4

Tetsuya Tanaka, Amandine Legat, Emmanuelle Adam et al. · European Journal of Immunology · 2008 · 97 citations

Life Sciences, Immunology, Pharmacology +17

<i>In vivo</i> and <i>in vitro</i> immunomodulation of Der p 1 allergen‐specific response by <i>Lactobacillus plantarum</i> bacteria

Michael Hisbergues, M. Magi, Peter Rigaux et al. · Clinical & Experimental Allergy · 2007 · 66 citations

Life Sciences, Immunology, Microbiology +17

Radiation therapy and concurrent plus adjuvant temsirolimus (CCI-779) versus chemoirradiation with temozolomide in newly diagnosed glioblastoma without methylation of the<i> MGMT </i>gene promoter.

Wolfgang Wick, Thierry Gorlia, Martin J. van den Bent et al. · Journal of Clinical Oncology · 2014 · 18 citations

Medicine, Oncology, Pharmacology +17

A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 ‘CREATE’ trial

Julien Péron, Sandrine Marréaud, Dominiek Staelens et al. · European Journal of Cancer · 2019 · 17 citations

Veterinary Medicine, Oncology, Neoplasia +9